Question follow-through · 94642
Cosmetics: Afamelanotide
To ask the Secretary of State for Health and Social Care, if he will set out the legal status of the sale of tan- enhancing nasal products containing Melanotan II for cosmetic purposes.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 26 Nov 2025
- Target answer date
- 1 Dec 2025
- Answer
- 3 Dec 2025 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Sodium Valproate and Surgical Mesh Implants: Compensation · 28 Nov 2025
- Health Services: Washington and Gateshead South · 16 Jan 2026
- Hearing Impairment: Children · 26 Jan 2026
- Tumours: Human Tissue · 20 Feb 2026
- Cancer: Genomics · 20 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
26 Nov 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will set out the legal status of the sale of tan- enhancing nasal products containing Melanotan II for cosmetic purposes.
1 Dec 2025
Target answer date
Date supplied by the official written-questions record.
3 Dec 2025
Answer published
The Medicines and Healthcare products Regulatory Agency (MHRA) is required to determine whether products are medicines on a case-by-case basis, taking into account the definition of a medicine in The Human Medicines Regulations 2012, relevant case law, an...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Sodium Valproate and Surgical Mesh Implants: Compensation
28 Nov 2025 · To ask the Secretary of State for Health and Social Care, if he will provide redress for mesh and sodium valproate families.
Health Services: Washington and Gateshead South
16 Jan 2026 · To ask the Secretary of State for Health and Social Care, what recent progress he has made in meeting the 18-week referral-to-treatment standard in Washington and Gateshead South constituency.
Hearing Impairment: Children
26 Jan 2026 · To ask the Secretary of State for Health and Social Care, what progress his Department has made on developing national guidance for Auditory Verbal therapy for deaf children since March 2025; and whether he plans to establish a timeline for publishing tha
Tumours: Human Tissue
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) monitor and (b) publish data on variation between NHS trusts and health boards in availability and use of frozen tumour tissue for sequencing and research
Cancer: Genomics
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, how his Department plans to ensure that the NHS Genomic Medicine Service’s pipeline of whole genome sequencing for cancer patients is unconstrained by local tissue storage practices; and whether th
Respiratory Diseases: Washington and Gateshead South
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what estimate her Department has made of the (a) prevalence of respiratory disease and (b) number of emergency hospital admissions for respiratory conditions in Washington and Gateshead South const
Respiratory Diseases: Health Services
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what her Department’s timeline is for deciding on the second wave of Modern Service Frameworks; and whether respiratory conditions will be considered.
NHS: Communication
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that NHS bodies consistently identify and implement reasonable adjustments to communication preferences, including where patients require written communication ra
Surgical Mesh Implants
3 Sept 2026 · To ask the Secretary of State for Health and Social Care, how many mesh removal surgeons are performing mesh removals since the setting up of the nine specialist removal centres in 2021.
Surgical Mesh Implants
3 Sept 2026 · To ask the Secretary of State for Health and Social Care, whether mesh removal surgeons receive an approved and accredited training course for removals.
Surgical Mesh Implants
3 Sept 2026 · To ask the Secretary of State for Health and Social Care, how many women have received full mesh removals since the setting up of the nine specialist removal centres in 2021, in comparison to partial removals.
Surgical Mesh Implants
3 Sept 2026 · To ask the Secretary of State for Health and Social Care, what work has been done in collaboration with international experts to reach a consensus on whether full or partial removals are best for mesh-harmed women; and whether NICE is actively monitoring